Sumitomo Pharma Co., Ltd.
住友ファーマ(株)
2026/08/21 Updated
Market Cap:
$4.1B (¥657.2B)
Stock Price:
$9.21 (¥1,465)
Exchange Rate: 1 USD = ¥158.98
【Sumitomo Pharma】Full-year Earnings Results for 2026 | Sales of ¥453.2 billion (up 13.7% YoY)
Sumitomo Pharma achieved significant profit growth in the fiscal year ending March 2026, with sales of ¥453.2 billion (13.7% increase) and net income attributable to owners of parent of ¥106.865 billion. The outlook for the full year 2027 forecasts sales of ¥540.0 billion and net income of ¥77.0 billion.
Key Figures
- Sales Revenue: ¥453.2 billion (up 13.7% YoY)
- Net Income Attributable to Owners of Parent: ¥106.865 billion (up 352.2% YoY)
- Forecasted Full-year Sales for 2027: ¥540.0 billion (up 19.1%)
AI要約
Overview of Performance
Outlook and Impact on Shareholders
This page uses AI to summarize IR materials from TDnet. Please refer to the original document for investment decisions.
Sumitomo Pharma Co., Ltd.
Company overview · Stock price · Financial data · All IR
